Are Analyst Price Targets Accurate? 7 Years of Data
How often Wall Street price targets are reached, how long it takes, and how the promised upside compares with what stocks actually did. From Exent’s backtest of 628,792 analyst ratings.
Exent ranks 129 healthcare analysts among Wall Street’s 1,000 by price‑target hit rate, returns after their calls and number of ratings, from a 7‑year backtest. How the sector’s analysts do, and who ranks below the members‑only top 50.
| Median across the sector’s analysts | Healthcare | All analysts |
|---|---|---|
| Price‑target hit rate | 37.7% | 52.4% |
| Calls up after 12 months | 52.9% | 64.0% |
| Median 12‑month return of calls | +4.2% | +13.4% |
| Median days to hit target | 105 days | 91 days |
The top 50 healthcare analysts are the ones Exent Gems follows in this sector. Who they are and what they are rating now is for members; their records are below.
| Sector rank | Analyst | Firm | Stars | Hit rate |
|---|---|---|---|---|
| #1 | 5.0★ | 56.6% | ||
| #2 | 5.0★ | 57.8% | ||
| #3 | 5.0★ | 28.0% | ||
| #4 | 5.0★ | 46.8% | ||
| #5 | 5.0★ | 47.2% | ||
| #6 | 5.0★ | 35.8% | ||
| #7 | 5.0★ | 33.6% | ||
| #8 | 5.0★ | 42.0% | ||
| #9 | 5.0★ | 27.5% | ||
| #10 | 5.0★ | 52.4% |
| Sector rank | Analyst | Firm | Stars | Hit rate | Newest ratings |
|---|---|---|---|---|---|
| #51 | Allison Bratzel | Piper Sandler | 4.8★ | 38.5% | After 3 days |
| #52 | Rami Katkhuda | LifeSci Capital | 4.8★ | 24.7% | After 3 days |
| #53 | Myles Minter | William Blair | 4.8★ | 50.0% | After 3 days |
| #54 | Yang Huang | J.P. Morgan | 4.8★ | 66.7% | After 3 days |
| #55 | Jason Butler | Citizens JMP | 4.8★ | 22.9% | After 3 days |
| #56 | Boris Peaker | JonesTrading | 4.8★ | 31.6% | After 3 days |
| #57 | Anupam Rama | J.P. Morgan | 4.8★ | 29.7% | After 3 days |
| #58 | Yasmeen Rahimi | Piper Sandler | 4.8★ | 15.9% | After 3 days |
| #59 | Dan Leonard | RBC Capital | 4.8★ | 54.9% | After 3 days |
| #60 | Jill Wu | CMB International Securities | 4.8★ | 48.2% | After 3 days |
| #61 | Arthur He CFA | H.C. Wainwright | 4.8★ | 7.5% | After 3 days |
| #62 | Graig Suvannavejh | Mizuho Securities | 4.8★ | 40.1% | After 3 days |
| #63 | Charles Zhu | LifeSci Capital | 4.8★ | 20.7% | After 3 days |
| #64 | Vamil Divan | Guggenheim | 4.8★ | 46.3% | After 3 days |
| #65 | Andrew Tsai | Jefferies | 4.8★ | 32.6% | After 3 days |
| #66 | Derek Archila | Wells Fargo | 4.8★ | 39.6% | After 3 days |
| #67 | David Martin PhD | Bloom Burton | 4.8★ | 38.0% | After 3 days |
| #68 | Andres Y. Maldonado | H.C. Wainwright | 4.8★ | 18.6% | After 3 days |
| #69 | Geoff Meacham | Citi | 4.8★ | 42.8% | After 3 days |
| #70 | Steven Lichtman | William Blair | 4.8★ | 47.2% | After 3 days |
| #71 | Gregory Renza | Truist Financial | 4.8★ | 31.2% | After 3 days |
| #72 | Annabel Samimy | Stifel Nicolaus | 4.8★ | 33.3% | After 3 days |
| #73 | Debjit Chattopadhyay | Guggenheim | 4.8★ | 35.3% | After 3 days |
| #74 | Allen Lutz | Bank of America Securities | 4.8★ | 56.4% | After 3 days |
| #75 | A.J. Rice | UBS | 4.8★ | 53.8% | After 3 days |
| #76 | John Ransom | Raymond James | 4.8★ | 49.9% | After 3 days |
| #77 | Joshua Schimmer | Cantor Fitzgerald | 4.8★ | 24.1% | After 3 days |
| #78 | Robert Burns | H.C. Wainwright | 4.7★ | 21.0% | After 3 days |
| #79 | Michael Wiederhorn | Oppenheimer | 4.8★ | 46.4% | After 3 days |
| #80 | Joseph Thome | TD Cowen | 4.8★ | 58.6% | After 3 days |
More healthcare analysts: Tara Bancroft · Charles Pitman CFA · Jack Meehan · Leonid Timashev · David Nierengarten · David Windley · Tom Godfrey · Swayampakula Ramakanth · Oliver McCammon · Kevin DeGeeter · Martin Fan · Andre Uddin · Silvan Tuerkcan · Mohit Bansal · Akash Tewari · Kristen Kluska · Clémence Thiers · Jayson Bedford · Sami Corwin · Douglas Loe · Sean Laaman · Nicolas Pauillac · Justin Walsh · Terence Flynn · Laura Chico · Russell Stanley · Catherine Novack · David Hoang · Cory Jubinville, PhD · Richard Close · Jason Zemansky · Tanushree Jain · Gil Blum · Dev Prasad · Whitney Ijem · Madison Elsaadi · Jeff Jones · Yanan Zhu · Ryan Deschner · Paul Matteis · Brian Abrahams · Yuan Zhi · Danielle Brill · Serge Belanger · Laura Prendergast · Phil Nadeau · Maxwell Skor · Jessica Fye · Ram Selvaraju
Every rating with a price target over a 7‑year lookback is replayed: was the target reached, how fast, and what the stock returned 1, 3, 6 and 12 months later. The ranking combines success rate, average return and number of ratings; the sector rank orders the analysts whose main sector is healthcare. Sector figures are medians, so one star analyst does not carry the group. All sectors and the overall ranking.
Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.
In Exent’s ranking, the top healthcare analyst reached 56.6% of price targets over a 7-year lookback, against a 37.7% median for the sector. The names and live calls of the top 50 healthcare analysts are members-only in Exent Gems (exent.ai/radar).
Across the 129 healthcare analysts in Exent’s ranking, the median price-target hit rate was 37.7% over a 7-year lookback, against 52.4% for all analysts, and a median 52.9% of their calls were up 12 months later.
Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.